APIGENEX s.r.o. offer service "Contract Research Service - CRO and R&D"

APIGENEX is a CRO based in Prague, Czech Republic, operating for more than 25 years, offering a complete package of high-quality (pre)clinical development services covering organic synthesis, peptides, peptidomimetics, PNA combinatorial libraries, analytical chemistry, and scale-up, transfer and development of clinical batches under cGMP, plus API production and experimental pharmacology in rodent models under GLP. A close partnership with Novo Nordisk Denmark supports research into treatments for diabetes, obesity, metabolic syndrome and toxicology, with the ability to synthesize potentially active compounds quickly and to high quality standards, including using shared biological data from customers.